Truluck Joseph has filed 3 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 25000 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on March 25, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Truluck Joseph | Chief Financial Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 1,424,661 | 9999.99% | 1.75% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Truluck Joseph | Chief Financial Officer | A | Common Stock | 157500 | $0.00 | 265,139.0000 | 26,463,559 | 146.32% | 0.60% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Truluck Joseph | Chief Financial Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 26,463,559 | 9999.99% | 0.47% |